| First Author | Park JS | Year | 2012 |
| Journal | Immunology | Volume | 137 |
| Issue | 4 | Pages | 326-35 |
| PubMed ID | 22812379 | Mgi Jnum | J:189620 |
| Mgi Id | MGI:5446566 | Doi | 10.1111/j.1365-2567.2012.03622.x |
| Citation | Park JS, et al. (2012) Interleukin-27 suppresses osteoclastogenesis via induction of interferon-gamma. Immunology 137(4):326-35 |
| abstractText | Interleukin (IL)-27 is a heterodimeric cytokine that is known to have both stimulatory and inhibitory functions during immune responses. We investigated the effects of IL-27 on arthritis and bone erosion in the murine collagen-induced arthritis (CIA) model. We demonstrate that the inhibitory effect of IL-27 on osteoclastogenesis is associated with interferon-gamma (IFN-gamma) production by using an IFN-gamma knockout mouse model. The IL-27-Fc was injected into both CIA and IFN-gamma-deficient mice. The effects of IL-27-Fc on osteoclast differentiation were evaluated both in vitro and in vivo. The IL-27-Fc-injected mice showed significantly lower arthritis indices and fewer tartrate-resistant acid-phosphatase-positive osteoclasts in their joint tissues than untreated mice. Interleukin-27 inhibited osteoclastogenesis from bone marrow-derived mononuclear cells in vitro, which was counteracted by the addition of anti-IFN-gamma antibody. The IL-27-Fc did not affect arthritis in IFN-gamma knockout mice. Interleukin-27 also suppressed osteoclast differentiation in human and intriguingly, it could promote the expression of IFN-gamma on priming osteoclasts. These results imply that IL-27 suppressed the generation of CIA and osteoclastogenesis, which were mediated by the induction of IFN-gamma. |
